• 1. An artificial photosynthetic system for photoaccumulation of two electrons on a fused dipyridophenazine (dppz)–pyridoquinolinone ligand?
  Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
• 2. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 3. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 4. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 5. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277

Recent Advances in the Application of 1,5-Dibromo-2-methyl-3-nitrobenzene (CAS: 67365-46-2) in Chemical and Biomedical Research

1,5-Dibromo-2-methyl-3-nitrobenzene (CAS: 67365-46-2) is a halogenated nitroaromatic compound that has garnered significant attention in recent years due to its versatile applications in chemical synthesis and biomedical research. This compound serves as a key intermediate in the synthesis of various pharmaceuticals, agrochemicals, and specialty chemicals. Recent studies have explored its potential in drug discovery, particularly in the development of novel antimicrobial and anticancer agents. The unique structural features of this compound, including the presence of bromine and nitro functional groups, make it a valuable building block for the construction of complex molecular architectures.

In a groundbreaking study published in the Journal of Medicinal Chemistry, researchers demonstrated the utility of 1,5-Dibromo-2-methyl-3-nitrobenzene as a precursor for the synthesis of potent kinase inhibitors. The study highlighted the compound's ability to undergo selective cross-coupling reactions, enabling the efficient construction of diverse heterocyclic scaffolds. These scaffolds were subsequently evaluated for their inhibitory activity against a panel of cancer-related kinases, with several derivatives exhibiting nanomolar potency. The findings underscore the potential of this compound in the design of targeted therapies for oncology applications.

Another notable application of 1,5-Dibromo-2-methyl-3-nitrobenzene was reported in the field of antimicrobial research. A team of scientists from leading pharmaceutical institutions utilized this compound as a starting material for the development of novel antibacterial agents. Through a series of structural modifications, they synthesized a library of derivatives with enhanced activity against multidrug-resistant bacterial strains. The most promising candidates demonstrated broad-spectrum activity, including against methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. These results were published in the Antimicrobial Agents and Chemotherapy journal, highlighting the compound's potential in addressing the global challenge of antibiotic resistance.

Recent advancements in synthetic methodology have also expanded the utility of 1,5-Dibromo-2-methyl-3-nitrobenzene. A study published in Organic Letters described a novel palladium-catalyzed coupling reaction that enables the selective functionalization of this compound at specific positions. This methodology provides access to previously inaccessible derivatives, opening new avenues for structure-activity relationship studies. The researchers demonstrated the application of this approach in the synthesis of fluorescent probes for biological imaging, showcasing the compound's versatility beyond traditional pharmaceutical applications.

From a safety and regulatory perspective, recent toxicological studies have provided valuable insights into the handling and use of 1,5-Dibromo-2-methyl-3-nitrobenzene. A comprehensive assessment published in Chemical Research in Toxicology evaluated the compound's environmental fate and ecotoxicological profile. The study established guidelines for safe handling procedures and waste management, ensuring compliance with current Good Manufacturing Practice (cGMP) standards. These findings are particularly relevant for industrial-scale applications of the compound in pharmaceutical manufacturing.

Looking ahead, the unique properties of 1,5-Dibromo-2-methyl-3-nitrobenzene continue to inspire innovative applications across multiple disciplines. Current research efforts are exploring its potential in materials science, particularly in the development of organic electronic materials and metal-organic frameworks. Additionally, its role in the synthesis of bioactive natural product analogs represents an exciting frontier in drug discovery. As synthetic methodologies advance and our understanding of structure-activity relationships deepens, this compound is poised to remain a valuable tool in chemical and biomedical research for years to come.

• 55289-35-5(1-Bromo-2-methyl-3-nitrobenzene)
• 95192-64-6(5-bromo-2-methyl-1,3-dinitro-benzene)
• 62827-39-8(3-Bromo-4-methyl-5-nitroaniline)
• 60956-26-5(4-bromo-1-methyl-2-nitro-benzene)
• 69383-59-1(1-Bromo-2,4-dimethyl-5-nitrobenzene)
• 15540-82-6(Benzene,2,3-dibromo-1,4-dimethyl-5-nitro-)
• 18242-38-1(1-Bromo-2-methyl-3,5-dinitrobenzene)
• 90561-85-6(3-Bromo-2,4,6-trimethylnitrobenzene)
• 6967-81-3(Benzene,1-bromo-2,4-dimethyl-3,5-dinitro-)
• 110127-07-6(1,3-Dibromo-2-methyl-5-nitrobenzene)